A/Prof An Duy Tran
Head - MISCH Health Economics Platform; Health Economics and Simulation Modelling Unit
Diabetes and endocrinology Rheumatic diseases Orthopaedic surgeries Intensive Care Physiotherapy Chronic kidney disease Cancer
Cost effectiveness modelling, Health policy evaluation, Health economic evaluation alongside registry-randomised trials, Trial-based economic evaluation, Analysing linked administrative data, Economic evaluation in LMIC, Health technology assessment, Research on patient-reported outcomes, Cost-benefit analysis, Budget impact analysis
Economic evaluations alongside clinical trials Development of simulation models to estimate long-term health outcomes in chronic diseases Analyses of linked administrative data
TRAN-DUY A, Morrisroe K, et al. Cost-effectiveness of combination therapy for patients with systemic sclerosis-related pulmonary arterial hypertension. J Am Heart Assoc 2020;10:e015816. http://doi.org/10.1161/jaha.119.015816
TRAN-DUY A, Knight J, et al. A patient-level model to estimate lifetime health outcomes of patients with type 1 diabetes. Diabetes Care 2020;43:1741-9. https://doi.org/10.2337/dc19-2249
TRAN-DUY A, Moghadam MG, Oude Voshaar MAH, et al. An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity: Results From a Pragmatic Open-Label Trial. Arthritis Rheumatol 2018:70:1557-1564. http://doi.org/10.1002/art.40546